Spain-based publicly listed healthcare company, Grifols, a manufacturer of plasma-derived medicines, has terminated discussions with Brookfield Capital Partners regarding a potential acquisition of Grifols shares. This followed the statement on…
Spain: Grifols ends acquisition discussions with Brookfield
…
…






